Specific distinguishing between miRNA and pre-miRNA by blocker displacement SMOS-qPCR

Guodong Zhao1, Yanmiao Dai2, Chenjing Xia2

  • 1Zhejiang University of Technology, Zhejiang, Hangzhou, 310014, China; ZJUT Yinhu Research Institute of Innovation and Entrepreneurship, Zhejiang, Hangzhou, 311400, China; Suzhou Key Laboratory of Integrated Traditional Chinese and Western Medicine for Digestive Diseases, Department of Spleen and Stomach Diseases, Kunshan Hospital of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Kunshan, Jiangsu, 215300, China; State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 211189, China.

Talanta
|June 4, 2025
PubMed

Insights

A new method, Blocker Displacement SMOS-qPCR, accurately quantifies microRNAs (miRNAs) by distinguishing mature forms from precursors. This advance improves miRNA biomarker reliability for disease detection.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • MicroRNAs (miRNAs) are vital regulators of biological processes.
  • Dysregulated miRNA expression is linked to various diseases.
  • Accurate quantification of mature miRNAs is crucial for biomarker development, but differentiating them from pre-miRNAs is challenging.

Purpose of the Study:

  • To develop a novel quantitative method for precise differentiation between mature microRNAs and pre-microRNAs.
  • To enhance the specificity of miRNA detection in biological samples.

Main Methods:

  • Introduction of Blocker Displacement SMOS-qPCR (BL-SMOS-qPCR).
  • Utilizing a blocker sequence complementary to pre-miRNA cDNA to prevent non-specific amplification.
  • Optimization of blocker modifications, length, concentration, and reaction temperature.

Main Results:

  • MGB-modified blockers significantly improved discrimination between mature miRNAs and pre-miRNAs, reducing pre-miRNA signals by ~3.2-fold.
  • BL-SMOS-qPCR demonstrated comparable dynamic ranges and R² values to the original SMOS-qPCR method.
  • The method successfully differentiated between normal controls and esophageal cancer patients using serum samples.

Conclusions:

  • BL-SMOS-qPCR offers a robust approach for precise miRNA quantification.
  • This method effectively addresses the challenge of distinguishing mature miRNAs from precursors in complex samples.
  • The technique shows promise for clinical applications in disease diagnostics.